Edition:
United States

Conmed Corp (CNMD.OQ)

CNMD.OQ on NASDAQ Stock Exchange Global Select Market

47.34USD
21 Apr 2017
Change (% chg)

-- (--)
Prev Close
$47.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
59,152
52-wk High
$50.16
52-wk Low
$37.66

Latest Key Developments (Source: Significant Developments)

Conmed corporation says jury found Surgiquest liable for $2.2 mln in compensatory damages
Tuesday, 11 Apr 2017 09:24pm EDT 

Conmed Corp : Conmed corporation announces jury verdict in delaware litigation against surgiquest . Jury in United States court for district of Delaware returned verdict finding conmed's subsidiary, surgiquest, liable for $2.2 million in compensatory damages . "this litigation will have no impact on availability of, or conmed's ability to distribute" .Conmed corp - surgiquest, is also liable for an additional $10.0 million in punitive damages.  Full Article

Conmed corporation says jury found Surgiquest liable for $2.2 mln in compensatory damages
Tuesday, 11 Apr 2017 06:40pm EDT 

Conmed Corp : Conmed corporation announces jury verdict in delaware litigation against surgiquest . Jury in United States court for district of Delaware returned verdict finding conmed's subsidiary, surgiquest, liable for $2.2 million in compensatory damages . "this litigation will have no impact on availability of, or conmed's ability to distribute" .Conmed corp - surgiquest, is also liable for an additional $10.0 million in punitive damages.  Full Article

Conmed Q4 adjusted earnings per share $0.54
Wednesday, 1 Feb 2017 04:01pm EST 

Conmed Corp : Conmed Corporation announces fourth quarter and fiscal year 2016 financial results . Q4 adjusted earnings per share $0.54 . Q4 GAAP earnings per share $0.24 . Q4 earnings per share view $0.56 -- Thomson Reuters I/B/E/S . Q4 sales $204.1 million versus I/B/E/S view $204 million . Expects 2017 constant currency sales growth in range of 1% to 3% . Conmed Corp -Company forecasts adjusted diluted net earnings per share in range of $1.85 to $1.95 in 2017 .FY2017 earnings per share view $1.91, revenue view $784.7 million -- Thomson Reuters I/B/E/S.  Full Article

Bovie medical announces sales partnership with CONMED for PlazXact
Thursday, 19 Jan 2017 08:00am EST 

Bovie Medical Corp : Bovie Medical announce sales channel partnership with conmed for plazxact(tm) . Bovie Medical Corp - entered into global sales channel partnership agreement with conmed for its PlazXact ablator .Bovie Medical Corp - PlazXact ablator will be marketed as ultrablator bipolar series effective in March 2017.  Full Article

Conmed Corporation announces Q2 2016 financial results
Wednesday, 27 Jul 2016 04:01pm EDT 

Conmed Corp : Conmed corp sees 2016 adjusted diluted net earnings per share are now expected to be in range of $1.83 to $1.9 . Conmed corporation announces second quarter 2016 financial results . Q2 adjusted earnings per share $0.47 . Q2 gaap earnings per share $0.10 . Q2 sales $193.4 million versus i/b/e/s view $191.5 million . Q2 earnings per share view $0.46 -- Thomson Reuters I/B/E/S . Sees fy 2015 revenue $719 million .Than-Anticipated organic sales growth.  Full Article

Conmed Corporation announces quarterly cash dividend
Tuesday, 23 Feb 2016 08:00am EST 

Conmed Corporation:Board of Directors has declared a quarterly cash dividend of $0.20 per share.Payable on April 5 to all shareholders of record date as of March 15.  Full Article

Conmed Corporation gives FY 2016 guidance
Wednesday, 27 Jan 2016 04:01pm EST 

Conmed Corporation:Forecasts Fy 2016 sales to be in the range of $760 to $770 million.Fy 2016 Revenue forecast includes constant currency organic sales growth of 1% to 3%, sales related to the SurgiQuest acquisition of $55 to $60 million and the negative impact of foreign exchange of $21 to $23 million.Forecasts Fy 2016 adjusted diluted cash earnings per share to be in the range of $1.85 to $1.95.Adjusted diluted cash EPS estimates for Fy 2016 exclude cost of special items including acquisition costs and restructuring costs which are estimated to be in range of $18 to $20 million, net of tax, and amortization of intangible assets estimated to be in range of $14 to $16 million, net of tax.  Full Article

Conmed Corp Completes Acquisition of SurgiQuest, Inc
Monday, 4 Jan 2016 04:43pm EST 

CONMED Corporation:completed its previously announced acquisition of privately-held SurgiQuest, Inc. (SurgiQuest), which will become part of the CONMED Advanced Surgical business.  Full Article

Conmed Corp declares quarterly cash dividend
Monday, 16 Nov 2015 04:01pm EST 

Conmed Corp:Declares quarterly cash dividend of $0.20 per share.Payable on Jan. 5, 2016 to all shareholders of record as of Dec. 15.  Full Article

Conmed Corporation announces definitive agreement to acquire SurgiQuest Inc
Monday, 16 Nov 2015 07:00am EST 

Conmed Corporation:Announces definitive agreement to acquire Surgiquest Inc.Deal for $265 million.Says deal valued at $265 million.Says transaction will be financed through a combination of cash and borrowings under a new credit facility.Conmed does not expect the acquisition to have a material impact on fiscal year 2015 operating results.On an adjusted cash EPS basis, the company expects the acquisition will provide double-digit accretion to fiscal 2016 earnings.Says in fiscal year 2016, the acquisition is expected to add $55 to $60 million to the company's revenue.Says plans to transition to reporting on an adjusted cash EPS basis for fiscal year 2016.Inclusive of intangible amortization, the company expects the acquisition to be slightly dilutive to fiscal 2016 earnings.Inclusive of intangible amortization, co expects the acquisition to generate double-digit earnings accretion after 2016.  Full Article

More From Around the Web

BRIEF-Lexion Medical says a jury found unit of CONMED Corp liable for false advertising

* Jury awards $10 million in punitive damages against SurgiQuest, a subsidiary of CONMED Corporation for false advertising in dispute with Lexion Medical